Overview

PTS is a company devoted to the design and manufacture of polypeptide-based materials for drug delivery and high tech applications. With more than 30 years of experience in polypeptide & materials science, drug delivery, custom manufacturing, analytical characterization and quality assurance we are committed to one purpose, your success.

Proprietary know-how & patent portfolio to provide an integrated solution from early/Academic research, through scale-up, to industrial GMP manufacturing, analytical development and regulatory affairs to reach the market. We have established an interdisciplinary team with strong skills and an intersectorial structure to allow your developments to progress throughout the different stages.

Our offer brings a solution in the polypeptide-based technology markets, covering an unmet need towards affordable and compliant polypeptide development and manufacturing.

Team

JOSE VICENTE PONS ANDREU

CHIEF EXECUTIVE OFFICER

Engineer, Masters degree in company planning, Karlsruhe Institute of Technology, Germany. MIT EDP Education. More that 20 years of experience in backing up, growing and financing of innovative health Companies. Founder and investor of multiple Health and Genetic tech companies in Europe and USA.

VICENT J. NEBOT

CHIEF TECHNICAL OFFICER

PhD. in Chemistry (Universitat Jaume I de Castelló, Spain) specialized in supramolecular chemistry, soft materials and polypeptide-based systems. 10 years of experience in the field of nanomaterials and drug delivery systems in both industry and academic settings.

MARC MARCO

CHIEF FINANCIAL OFFICER

Economist. Degree in Administration and Business Management. Master in Management Control and Finance and Master in Spanish Taxation. More than 10 years of experience as a consultant of startups and biotechnological companies.

JOSE CONEJOS

QUALIFIED PERSON / HEAD OF QUALITY ASSURANCE

Pharmacist, Master’s degree in pharmaceutical industry and in biomedical biotechnology. More than 10 years working under GMP environment, inspecting GMP, GDP and GLP quality systems of Pharmaceutical and Cosmetic companies.

SERGIO ABAD

HEAD OF QUALITY CONTROL

PhD in Chemistry (Universidad Politécnica de Valencia, Spain). Over 10 years experience in the development, validation and transfer of production and analytical methods for active ingredients and drug products.

DANIEL MORELLÓ

HEAD OF PRODUCT DEVELOPMENT

Graduated in Chemistry from University of Valencia. More than 4 years experience in synthesis, process development and analytical methods for polypeptides and hybrids hydrogels. PhD to be defended in 2019.

LUZ TORTAJADA

R&D, PRODUCT DEVELOPMENT

Graduated in Chemistry from University of Valencia. Master’s degree in Innovation from EOI in Madrid. More than 4 years experience in development and manufacturing of polypeptides.

LOLA IBORRA

PRODUCTION TECHNICIAN

Senior laboratory technician with training in manufacturing processes and new developments of cosmetic products. Also, she is involved in GMP procedures and she has more than 8 years of experience in the industry.

ELENA GALLON

R&D, PRODUCT DEVELOPMENT

PhD. in Molecular Sciences with specialization in Pharmaceutical Sciences (2014, University of Padua, Italy). She has developed her professional career in the research field contributing to the development of polymeric systems for cancer treatment.

JACIEL RABIONET

QUALITY CONTROL TECHNICIAN

M.Sc. in Bioinformatics, Computational Biology and Experimental techniques in Chemistry (Universidad de Valencia, Spain). More than 8 years experience in the quality control of pharmaceutical of raw materials and finished products in cosmetic and pharmeceutical industry.

Advisory Board

MARIA JESUS VICENT

CO-FOUNDER, CHAIRMAN OF THE BOARD – EXPERT IN POLYMER THERAPEUTICS

She Joined the Centre for Polymer Therapeutics with Prof. R. Duncan after the award of a Marie Curie Postdoctoral Fellowship in 2002. In 2004, María joined the Centro de Investigación Príncipe Felipe (CIPF) as a research associate through a Marie Curie Reintegration contract and was promoted to her current position as head of the Polymer Therapeutics Laboratory at the CIPF in 2006. She is also the responsible of the Screening Platform and the Advanced Therapies Program Coordinator at CIPF. Her research interests focuses on the development of novel nanopharmaceuticals for different therapeutic applications and has been funded by national and European grants (several acting as coordinator including a recently awarded ERC Consolidator grant MyNano) from academia as well as industry.

Quality System

The quality area of PTS integrates two departments: Quality Assurance and Regulatory Affairs Department (QA) and the Quality Control Department (QC). PTS sets high quality requirements in order to integrate GMP, GLP and GDP quality standards.

Our analytical laboratory is staffed by highly-qualified personnel who use equipment specially focused, but not limited, to the quality control of polymers. All instruments are qualified, and the analysis validated conform to international and European standards.

Our facilities

PTS facilities are independent and fully equipped to boost your developments.

Full equipped R&D and organic laboratory for lab scale synthesis & first stage scale-up.

Paralel chemistry stations 12 x 50mL

Paralel chemistry stations 6 x 250mL

Radley´s Reactor-Ready Lab 2 x 1, 2 and 5 L

Reaction processing & purification equipment

Manufacturing room - pilot plant for process development, scale-up and preclinical batches.

Over-pressure room equipped with EPA filters and SAS entry.

Data loggers (temperature and moisture).

Full equipped pilot plant (walk-in hood, Reactor-Ready Pilot 20L, Reaction processing & purification equipment).

Regular maintenance and sterilization, microbiological and endotoxin controlled area.

Physico-chemical Characterisation

We have built a collaboration framework with different research centres and industrial partners allowing us to access cutting-edge instrumentation for the physico-chemical characterization of polymers, APIs and nanomaterials.

GLP certified Quality Control laboratory.

200m2 GMP facilities equipped with Pilot Kilo-labs

Devoted to the manufacturing of small batches of investigational medicinal products for preclinical and early clinical trials. Special focus on polymer therapeutics, polypeptide-based materials and nanomedicines. GMP manufacture of key starting materials and active pharmaceutical ingredients.